(Q41106487)

26 September 2017

1 reference

title

The non-ionic isotonic contrast agents. Perspectives and controversies (English)

1 reference

26 September 2017

1 reference

P Dawson

1

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

26 September 2017

1 reference

26 September 2017

volume

6 Suppl 2

1 reference

26 September 2017

page(s)

S20-4

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02342568

26 September 2017

exact match

0 references

cites work

Nonionic dimer: development and initial testing of an intrathecal contrast agent

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02342568

Iodixanol in excretory urography: initial clinical experience with a nonionic, dimeric (ratio 6:1) contrast medium. Work in progress

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02342568

Vascular endothelial injury by intravascular contrast agents

21 January 2018

1 reference

12 December 2020

Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers

1 reference

12 December 2020

Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml

1 reference

12 December 2020

The non-ionic dimers: a new class of contrast agents

1 reference

12 December 2020

Histamine release induced by radiographic contrast media. Comparison between pulmonary and peritoneal mast cells derived from normotensive and spontaneously hypertensive rats

1 reference

12 December 2020

The persistent computed tomography nephrogram: its significance in the diagnosis of contrast-associated nephrotoxicity

1 reference

12 December 2020

Effects of intravascular contrast media on blood-brain barrier. Comparison between iothalamate, iohexol, iopentol and iodixanol.

1 reference

12 December 2020

Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02342568

1 reference

26 September 2017

1 reference